Preoperative Evaluation of Airway

July 21, 2018 updated by: nurcan kizilcik, Yeditepe University Hospital

Evaluation of Airway on Undervent Bariatric Surgery Patients

Evaluation of airway markers of patients who have undergone obesity surgery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The investigators evaluated the airway parameters recorded preoperatively for patients with BMI> 30 who were undervent bariatric surgery between 2015-2018 in terms of difficult airway.

Study Type

Interventional

Enrollment (Actual)

489

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. BMI>30kg/m2
  2. 18<age <65
  3. elective surgery planned
  4. ASA II-III

Exclusion Criteria:

  1. BMI<30kg/m2
  2. 18>age >65
  3. ASA IV

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: obese patient
BMI>30 kg/m2 and underwent bariatric surgery
underwent bariatric surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
airway evaluation for menagement in obese patient
Time Frame: 3 year
preoperative airway measurements routinely performed (mallampati score, thyromental distance, neck circumference ..)for each patient will be evaluated
3 year
mallampati score
Time Frame: 3 year
Class I : Visualization of the soft palate, fauces; uvula, anterior and the posterior pillars. Class II : Visualization of the soft palate, fauces and uvula. Class III : Visualization of soft palate and base of uvula. Class IV: Only hard palate is visible. Soft palate is not visible at all.
3 year
thyromental distance
Time Frame: 3 year
TMD was measured as straight distance between thyroid notch and lower border of mental prominence.(cm)
3 year
neck circumference
Time Frame: 3 year
Neck Circumference was measured in the midway of the neck, between mid-cervical spine and mid anterior neck, to within 1 mm, using non-stretchable plastic tape with the subjects standing upright.
3 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: nurcan kizilcik, Yeditepe UH

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

May 16, 2018

First Submitted That Met QC Criteria

July 21, 2018

First Posted (Actual)

July 24, 2018

Study Record Updates

Last Update Posted (Actual)

July 24, 2018

Last Update Submitted That Met QC Criteria

July 21, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • YeditepeUH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

For the protection of personal data, was decided that the personal data of the participants should not be shared .

IPD Sharing Time Frame

3 years

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on obese patients

3
Subscribe